Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.

NCT00967421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-10-02

No results posted yet for this study

Summary

The purpose of the validation study is to develop a valid test battery for assessing driving ability in a driving simulator when influenced by drugs. Ethanol has known, well-documented and well-characterized effects on driving behaviour and accident risk, and will be used to assess the simulator test scenarios' sensitivity to drug effects. Once the test scenarios have been refined and their ability to predict driving accident risk have been validated, we plan to use the simulator to assess driving ability under the influence of different drugs suspected to produce driving impairment.

Conditions

  • Automobile Driving

Interventions

DRUG

ethanol

BAC level 0.5 g/dL (drink + placebo pill). Drink with 2,4 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.

DRUG

Ethanol

BAC level 1.0 g/dL (drink + placebo pill). Drink with 3,6 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.

OTHER

Placebo drink

Placebo drink containing no alcohol + placebo pill

Sponsors & Collaborators

  • SINTEF Health Research

    collaborator OTHER
  • Norwegian University of Science and Technology

    collaborator OTHER
  • Norwegian Institute of Public Health

    collaborator OTHER_GOV
  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Lars Slørdal, PhD, MD · Norwegian University of Science and Technology

  • Gunnar D Jenssen · SINTEF Health Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-11-30
Completion
2010-11-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00967421 on ClinicalTrials.gov